Vistin Pharma ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	3.4	12.79	26.2	1.44	35.75	77.04
Cash & Short-Term Investments	3.4	12.79	26.2	1.44	35.75	77.04
Cash Growth	-39.71%	-51.18%	1726.06%	-95.99%	-53.60%	-75.90%
Accounts Receivable	85.34	44.28	47.02	66.16	40.25	30.4
Other Receivables	10.01	7.7	12.56	5.01	2.85	1.45
Receivables	95.35	51.98	59.59	71.17	43.09	31.85
Inventory	91.39	76.67	80.17	83.45	42.91	31.79
Prepaid Expenses	-	1.75	2.81	3.14	16.09	0.85
Other Current Assets	0	-	-	-	-	-
Total Current Assets	190.14	143.19	168.77	159.18	137.83	141.53
Property, Plant & Equipment	222.78	229.6	219.98	219.43	167.46	145.26
Long-Term Deferred Tax Assets	-	-	14.64	28.6	27.86	35.13
Other Long-Term Assets	12.16	12.16	-	-	0	-
Total Assets	425.07	384.95	403.4	407.21	333.15	321.92
Accounts Payable	19.68	13.05	18.92	25.91	20.81	17.89
Accrued Expenses	-	15.82	16.59	14.67	16.58	11.69
Short-Term Debt	21.02	-	-	45.14	-	-
Current Portion of Leases	0.87	-	-	1.07	0.88	-
Other Current Liabilities	43.52	35.1	33.96	30.78	2.78	2.62
Total Current Liabilities	85.09	63.97	69.47	117.57	41.04	32.2
Long-Term Leases	0.83	1.33	-	2.96	0.51	-
Pension & Post-Retirement Benefits	6.28	6.6	8.86	13.2	15.83	16.33
Long-Term Deferred Tax Liabilities	20.07	3.52	-	-	-	-
Other Long-Term Liabilities	-	0	2.29	-0	0	0.98
Total Liabilities	112.27	75.42	80.63	133.73	57.38	49.51
Common Stock	44.35	44.35	44.35	44.35	44.35	44.35
Additional Paid-In Capital	73.87	129.3	206.89	206.89	206.89	229.06
Retained Earnings	194.58	135.89	71.54	22.26	24.54	-1
Shareholders' Equity	312.8	309.53	322.77	273.49	275.77	272.41
Total Liabilities & Equity	425.07	384.95	403.4	407.21	333.15	321.92
Total Debt	22.72	1.33	-	49.17	1.39	-
Net Cash (Debt)	-19.33	11.47	26.2	-47.73	34.36	77.04
Net Cash Growth	-	-56.24%	-	-	-55.40%	-75.71%
Net Cash Per Share	-0.44	0.26	0.59	-1.08	0.77	1.74
Filing Date Shares Outstanding	44.34	44.34	44.34	44.34	44.34	44.34
Total Common Shares Outstanding	44.34	44.34	44.34	44.34	44.34	44.34
Working Capital	105.04	79.22	99.3	41.61	96.8	109.32
Book Value Per Share	7.05	6.98	7.28	6.17	6.22	6.14
Tangible Book Value	312.8	309.53	322.77	273.49	275.77	272.41
Tangible Book Value Per Share	7.05	6.98	7.28	6.17	6.22	6.14
Machinery	-	268.64	263.53	253.37	-	87.23
Construction In Progress	-	39.09	17.91	10.24	-	56.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.